Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [Eur Heart J 2008;29:2388-2442]
Kenneth Dickstein, K. Swedberg, Piotr Ponikowski(Wroclaw Medical University), John J.V. McMurray(British Heart Foundation), S. G. Priori, Dirk J. van Veldhuisen(University Medical Center Groningen), G. Filippatos, Anna Strömberg(Linköping University), Dan Atar, Alexandre Mebazaa(Délégation Paris 5), A Cohen-Solal, A. W. Hoes, Andre Keren, PA Poole-Wilson, Melina Nieminen-Kelhä(Humboldt-Universität zu Berlin)
Cited by 189
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k